Half-year report · Q2
7915.TEDINET S100U55C
Period2024-01-01 → 2024-06-30
Filed2024-08-07
StandardIFRS
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 40
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | ¥4.4bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥58m | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥6.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥2.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥1.1bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥4.4bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥3.0bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥801m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥4.5bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥786m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥257.0bn | at 2024-06-30 | Cons. | Assets IFRS |
| Total assets | ¥217.9bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥229.7bn | at 2023-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥135.3bn | at 2024-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥107.0bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥121.7bn | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥110.9bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥116.5bn | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥111.5bn | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥121.2bn | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥110.9bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥116.5bn | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥44.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥37.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥46.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥10.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥1.5bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥13.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥8.0bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥4.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥5.8bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥12.6bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥4.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥90.22 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-61.13 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥16.36 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| Equity ratio | 47.2% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.9% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.7% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 14
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥420m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥915m |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥2.7bn |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥5.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | −¥455m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥758m |
| jpcrp040300-q2r_E00703-000Devicesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E00703-000Industrial Materialsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00703-000Medical Technologiesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥816m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 835
| Item | Context | Value | Unit |
|---|---|---|---|
| Finance costs IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Finance costs IFRS | Prior1YTDDuration | 779000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 1087000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 37220000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 36273000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 22024000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_ReportableSegmentsMember | 95518000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 4142000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 99661000000 | JPY |
| Sales to external customers IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Sales to external customers IFRS | CurrentYTDDuration | 99661000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 30000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 0 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | － | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_ReportableSegmentsMember | 30000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 486000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 517000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration_ReconcilingItemsMember | -517000000 | JPY |
| Intersegment sales IFRS | CurrentYTDDuration | － | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 37250000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 36274000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 22024000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_ReportableSegmentsMember | 95549000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 4629000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 100179000000 | JPY |
| Net sales IFRS | CurrentYTDDuration_ReconcilingItemsMember | -517000000 | JPY |
| Net sales IFRS | CurrentYTDDuration | 99661000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | 2699000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | 1873000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember | 1168000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 5740000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -420000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 5320000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | -915000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 4405000000 | JPY |
| Finance income IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember | － | JPY |
| Finance income IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |